Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Pfizer CEO Dr. Albert Bourla speaks to CNN’s Meg Tirrell about pushing past vaccine skepticism to work with the Trump ...

Kindler and his wife, Sharon Sullivan, who works in the performing arts, have listed a four-bedroom, four-bath condo on West ...

They are two of the biggest rivals in the world of pharma. But the CEO of drug giant Pfizer has sprung to Moderna's defense following the Trump administration's decision to cut its funding for ...

We speak with the Co-Chair of The Left Group in the European Parliament, French MEP Manon Aubry. A noted advocate for ...

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

Shares of Pfizer have fallen about 62% from their COVID-19 pandemic highs. The stock is way down, but the company has raised ...

A Connecticut doctor who is an expert in his field said it is “one of the silent diseases that does not get the respect it ...

Earlier research has suggested that regular exercise can improve survival rates for colorectal cancer patients, and a new ...

Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.